Novavax's unique Nuvaxovid approval may represent the beginning of a new era in less predictable vaccine and drug regulation under the Trump Administration. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
